Blue Cross Insurers To Create Their Own Drug Company Amid Price Fight [Forbes]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Forbes
Blue Cross and Blue Shield health insurers are launching their own nonprofit drug company with Civica Rx The Blue Cross Blue Shield Association new drug applications (ANDAs) These health insurers won’t be investing in research and development like brand name drug giants Pfizer or Merck, but will partner with Civica “and manufacturing partners to bring more affordable generic drugs to uncompetitive markets in exchange for aggregate volume and multiyear purchasing commitments.” Thus, the Blue Cross-Civica Rx venture will act more like a generic drug maker that acquires and develops prescriptions and gets regulatory approval of ANDAs has already grabbed headlines by three philanthropies This time, Civica is moving into the retail and outpatient healthcare setting in a move that could have a much broader impact on the prices consumers pay for prescription drugs. “We are still focusing on generic drugs . . . ones that have artificially high prices in outpatient settings,” Civica Rx chief e
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights [Reuters]Reuters
- Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage [Yahoo! Finance]Yahoo! Finance
- Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]Yahoo! Finance
- UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website